Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $250.0 to $405.0 for Lululemon Athletica over the last 3 months.

Olema Pharmaceuticals is developing palazestrant, an oral SERD in phase 3 trials for ER+/HER2- metastatic breast cancer. Read why OLMA stock is a Hold.

The Floodlight MS app, used to track disease progression in people with multiple sclerosis, has been deemed cost-effective in ...

Amidst a federal pushback on celebrations of heritage and race — marked in part by federal agencies pausing observances of ...

Bloodlines 2 have revealed how the Masquerade mechanics work in the game, with players forced to hide their supernatural ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

Shares of Biodexa Pharmaceuticals skyrocketed nearly 50% on Monday, hitting their highest level since early December. The ...

After beating the first encounter and exploring the sewers of the pyramid ship, you’re now at the most unorthodox fight of ...

Black Ops 6, players are scrambling to complete a difficult Easter Egg/quest in Zombies, featuring one of the hardest boss ...

Similar to the first game's optional boss, Ratnor Rodentson, the Tails of Iron 2: Whiskers of Winter introduces its own ...

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of BRAFTOVI ...

Our study's goal was to screen novel biomarkers that could accurately predict the progression and prognosis of bladder ... and chose the C2 (c2.cp.kegg.v6.1.symbols.gmt) sub-collection downloaded from ...